EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Androgen receptor knockdown enhances prostate cancer chemosensitivity by down‐regulating FEN1 through the ERK / ELK1 signalling pathway

Weijie Xie iD, Shulin Li, Huan Guo, Jiawei Zhang, Menjiang Tu, Rui Wang, Bingling Lin, Yuqi Wu iD, Xiangwei Wang iD

Cancer Medicine · 2023

DOI: 10.1002/cam4.6188 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Weijie Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology and Carson International Cancer Center, Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy C…. Hauptthemen laut MEDLINE: Receptors, Androgen, Prostatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Flap endonuclease 1 (FEN1) is highly upregulated in prostate cancer and promotes the growth of prostate cancer cells. Androgen receptor (AR) is the most critical determinant of the occurrence, progression, metastasis, and treatment of prostate cancer. However, the effect of FEN1 on docetaxel (DTX) sensitivity and the regulatory mechanisms of AR on FEN1 expression in prostate cancer need to be further studied.

Methods

Bioinformatics analyses were performed using data from the Cancer Genome Atlas and the Gene Expression Omnibus. Prostate cancer cell lines 22Rv1 and LNCaP were used. FEN1 siRNA, FEN1 overexpression plasmid, and AR siRNA were transfected into cells. Biomarker expression was evaluated by immunohistochemistry and Western blotting. Apoptosis and the cell cycle were explored using flow cytometry analysis. Luciferase reporter assay was performed to verify the target relationship. Xenograft assays were conducted using 22Rv1 cells to evaluate the in vivo conclusions.

Results

Overexpression of FEN1 inhibited cell apoptosis and cell cycle arrest in the S phase induced by DTX. AR knockdown enhanced DTX‐induced cell apoptosis and cell cycle arrest at the S phase in prostate cancer cells, which was attenuated by FEN1 overexpression. In vivo experiments showed that overexpression of FEN1 significantly increased tumour growth and weakened the inhibitory effect of DTX on prostate tumour growth, while AR knockdown enhance the sensitivity of DTX to prostate tumour. AR knockdown resulted in FEN1, pho‐ERK1/2, and pho‐ELK1 downregulation, and the luciferase reporter assay confirmed that ELK1 can regulate the transcription of FEN1.

Conclusion

Collectively, our studies demonstrate that AR knockdown improves the DTX sensitivity of prostate cancer cells by downregulating FEN1 through the ERK/ELK1 signalling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AndrogenProstatic NeoplasmsMaleHumansMAP Kinase Signaling SystemFlap EndonucleasesCell ProliferationCell Line, TumorDocetaxelRNA, Small Interferingets-Domain Protein Elk-1

Stichwörter der Autor:innen

MAPK/ERK signalling pathwayandrogen receptorflap endonuclease 1prostate cancer

Substanzen

Receptors, AndrogenFlap EndonucleasesDocetaxelRNA, Small InterferingFEN1 protein, humanELK1 protein, humanets-Domain Protein Elk-1

Autor:innen und Institutionen

  • Department of Urology and Carson International Cancer Center, Shenzhen University General Hospital and Shenzhen University Clinical Medical Academy Center, Shenzhen University, Shenzhen, People's Republic of China.
  • Department of Urology, Affiliated Hospital of Guangdong Medical University, Guangdong Province, Zhanjiang, People's Republic of China.
  • Department of Radiology, Peking University Shenzhen Hospital, Shenzhen, People's Republic of China.

ORCID-Profile: Weijie Xie, Yuqi Wu, Xiangwei Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xie, W., Li, S., Guo, H., Zhang, J., Tu, M., Wang, R., Lin, B., Wu, Y., & Wang, X. (2023). Androgen receptor knockdown enhances prostate cancer chemosensitivity by down‐regulating FEN1 through the ERK / ELK1 signalling pathway. Cancer Medicine. https://doi.org/10.1002/cam4.6188

Vancouver

Xie W, Li S, Guo H, Zhang J, Tu M, Wang R, et al. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down‐regulating FEN1 through the ERK / ELK1 signalling pathway. Cancer Medicine. 2023. doi:10.1002/cam4.6188

BibTeX
@article{Xie2023,
  author = {Xie, Weijie and Li, Shulin and Guo, Huan and Zhang, Jiawei and Tu, Menjiang and Wang, Rui and Lin, Bingling and Wu, Yuqi and Wang, Xiangwei},
  title = {Androgen receptor knockdown enhances prostate cancer chemosensitivity by down‐regulating FEN1 through the ERK / ELK1 signalling pathway},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6188}
}
Kostenlos starten →